Naloxegol

Moventig 12,5 MG Comprimidos Recubiertos con Pelicula

14,2 mg comprimido recubierto con películaSpainMarketedAuthorised 18 Feb 2015

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Naloxegol

Moventig 12,5 MG Comprimidos Recubiertos con Pelicula

14,2 mg comprimido recubierto con películaSpainMarketedAuthorised 18 Feb 2015

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

NaloxegolUnited States · 12.5MG, 25MG · tablet · MSN Labs PVT LTD

Packs

Pack	Code	Status
MOVENTIG 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos	705258
MOVENTIG 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos (unidosis)	720858

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Naloxegol
Strength: 14,2 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 18 Feb 2015
Registration: 114962001
Marketing authorisation holder: Grünenthal Gmbh
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica